Vertex Pharmaceuticals Incorporated shares owned by Wilbanks Smith & Thomas Asset Management
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Wilbanks Smith & Thomas Asset Management
from 13F filings
Historical chart of Wilbanks Smith & Thomas Asset Management investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Wilbanks Smith & Thomas Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Wilbanks Smith & Thomas Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.2M | 2.9k | 418.01 |
| 2023-12-31 | $1.2M | 2.9k | 406.89 |
| 2023-09-30 | $1.0M | 2.9k | 347.74 |
| 2023-06-30 | $1.0M | 2.9k | 351.91 |
| 2023-03-31 | $931k | 3.0k | 315.07 |
| 2022-12-31 | $855k | 3.0k | 288.78 |
| 2022-09-30 | $858k | 3.0k | 289.57 |
| 2022-06-30 | $839k | 3.0k | 281.92 |
| 2022-03-31 | $795k | 3.0k | 269.22 |
| 2021-12-31 | $635k | 2.9k | 219.50 |
| 2021-09-30 | $528k | 2.9k | 181.32 |
| 2021-06-30 | $591k | 2.9k | 201.71 |
| 2021-03-31 | $658k | 3.1k | 214.75 |
| 2020-12-31 | $753k | 3.2k | 236.42 |
| 2020-09-30 | $862k | 3.2k | 272.10 |
| 2020-06-30 | $920k | 3.2k | 290.40 |
| 2020-03-31 | $728k | 3.1k | 238.06 |
| 2019-12-31 | $626k | 2.9k | 218.80 |
| 2019-09-30 | $485k | 2.9k | 169.52 |
| 2019-06-30 | $525k | 2.9k | 183.50 |
| 2019-03-31 | $526k | 2.9k | 183.85 |
| 2018-12-31 | $474k | 2.9k | 165.68 |
| 2018-09-30 | $551k | 2.9k | 192.59 |
| 2018-06-30 | $486k | 2.9k | 169.87 |
| 2018-03-31 | $459k | 2.8k | 163.06 |
| 2017-12-31 | $422k | 2.8k | 149.91 |
| 2017-09-30 | $522k | 3.4k | 152.05 |
| 2017-06-30 | $363k | 2.8k | 128.95 |
| 2017-03-31 | $308k | 2.8k | 109.41 |
| 2016-12-31 | $207k | 2.8k | 73.53 |
| 2016-09-30 | $245k | 2.8k | 87.03 |
| 2016-06-30 | $246k | 2.9k | 86.16 |
| 2016-03-31 | $227k | 2.9k | 79.51 |
| 2015-12-31 | $359k | 2.9k | 125.74 |
| 2015-09-30 | $297k | 2.9k | 104.03 |
| 2015-06-30 | $353k | 2.9k | 123.64 |
| 2015-03-31 | $340k | 2.9k | 118.10 |
| 2014-12-31 | $337k | 2.8k | 118.83 |
| 2014-09-30 | $316k | 2.8k | 112.26 |
| 2014-06-30 | $267k | 2.8k | 94.85 |
| 2013-12-31 | $209k | 2.8k | 74.25 |
| 2013-09-30 | $216k | 2.8k | 75.98 |
| 2013-06-30 | $229k | 2.9k | 80.01 |
More positions owned by Wilbanks Smith & Thomas Asset Management
View all positions for Wilbanks Smith & Thomas Asset Management
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated